Aerosol and injectable formulations of nanoparticulate benzodiazepine
Details for Australian Patent Application No. 2006214443 (hide)
International Classifications
Event Publications
27 September 2007 PCT application entered the National Phase
PCT publication WO2006/088894 Priority application(s): WO2006/088894
16 June 2011 Application Accepted
Published as AU-B-2006214443
4 August 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 15 Jul 2011. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000
24 November 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 15 Jul 2011
1 December 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006214444-Compositions and methods for detecting pathogen specific nucleic acids in urine
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser